Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Molina-Cerrillo

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Targeted Oncology|March 12, 2021
Coming of Age of Immunotherapy of Urothelial CancerEnrique Grande, Javier Molina-Cerrillo, Andrea Necchi
The Oncologist|March 17, 2019
Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long-Term Efficacy in a Patient with Gastrointestinal Neuroendocrine TumorJavier Molina-Cerrillo, Enrique Grande, Teresa Alonso-Gordoa
Current Treatment Options in Oncology|May 2, 2022
High-Dose Somatostatin Analogs for the Treatment of Neuroendocrine Neoplasms: where are we Now?Teresa Alonso-Gordoa, Ray Manneh, Enrique Grande, et al.
Oncotarget|June 18, 2020
Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutationJavier Molina-Cerrillo, Teresa Alonso-Gordoa, Alfredo Carrato, et al.
The Oncologist|April 24, 2016
Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine TumorsJavier Molina-Cerrillo, Teresa Alonso-Gordoa, Olga Martínez-Sáez, et al.
Biomedicines|April 3, 2021
Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of ResistanceMarta Araujo-Castro, Eider Pascual-Corrales, Javier Molina-Cerrillo, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategyOlga Martínez-Sáez, Pablo Gajate Borau, Teresa Alonso-Gordoa, et al.
Healthcare (Basel, Switzerland)|January 20, 2021
May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic LeukemiaJavier Molina-Cerrillo, Juan Marquet-Palomanes, Teresa Alonso-Gordoa, et al.
Endocrinologia, Diabetes Y Nutricion|November 19, 2022
Role of imaging test with radionuclides in the diagnosis and treatment of pheochromocytomas and paragangliomasMarta Araujo-Castro, Eider Pascual-Corrales, Teresa Alonso-Gordoa, et al.
European Urology Oncology|October 9, 2025
Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder CancerJavier Molina-Cerrillo, James Catto, Ashish M Kamat, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Targeted Oncology|March 12, 2021
Coming of Age of Immunotherapy of Urothelial CancerEnrique Grande, Javier Molina-Cerrillo, Andrea Necchi
The Oncologist|March 17, 2019
Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long-Term Efficacy in a Patient with Gastrointestinal Neuroendocrine TumorJavier Molina-Cerrillo, Enrique Grande, Teresa Alonso-Gordoa
Current Treatment Options in Oncology|May 2, 2022
High-Dose Somatostatin Analogs for the Treatment of Neuroendocrine Neoplasms: where are we Now?Teresa Alonso-Gordoa, Ray Manneh, Enrique Grande, et al.
Oncotarget|June 18, 2020
Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutationJavier Molina-Cerrillo, Teresa Alonso-Gordoa, Alfredo Carrato, et al.
The Oncologist|April 24, 2016
Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine TumorsJavier Molina-Cerrillo, Teresa Alonso-Gordoa, Olga Martínez-Sáez, et al.
Biomedicines|April 3, 2021
Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of ResistanceMarta Araujo-Castro, Eider Pascual-Corrales, Javier Molina-Cerrillo, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategyOlga Martínez-Sáez, Pablo Gajate Borau, Teresa Alonso-Gordoa, et al.
Healthcare (Basel, Switzerland)|January 20, 2021
May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic LeukemiaJavier Molina-Cerrillo, Juan Marquet-Palomanes, Teresa Alonso-Gordoa, et al.
Endocrinologia, Diabetes Y Nutricion|November 19, 2022
Role of imaging test with radionuclides in the diagnosis and treatment of pheochromocytomas and paragangliomasMarta Araujo-Castro, Eider Pascual-Corrales, Teresa Alonso-Gordoa, et al.
European Urology Oncology|October 9, 2025
Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder CancerJavier Molina-Cerrillo, James Catto, Ashish M Kamat, et al.
Pageof 10